Ubiquinone
In clinical developmentAlso known as COENZYME Q10, Carni Q-Gel Forte, Chew Q, Co Enzyme Q10+23 more
COENZYME Q10, Carni Q-Gel Forte, Chew Q, Co Enzyme Q10, Co Q-10, Co-Enzyme Q-10 (Ubiquinone), Co-Enzyme Q10, Co-Q10, Co-enzyme Q 10, CoQ-10 (Ubiquinone), CoQ10, Coenzyme Co Q10, Coenzyme Q 10, Coenzyme Q-10, H2Q, LiQ-10, LiQsorb, Liquid Co-Q10, NeoQ10, NutraDrops, Q-Gel, Q-Gel with Lipoic Acid, Q-Sorb Co Q-10, Q-Up, QuinZyme, UBIDECARENONE, Vitamin Q10.
Recent clinical, regulatory, research and industry developments relating to this drug.
Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study
Neuroprotective Effects of Coenzyme Q10 in Paclitaxel-Induced Peripheral Neuropathy
Copper metabolism in cell death and autophagy.
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes7
Journals, researchers & institutions
- Annals of neurology1
- Autophagy1
- Nature communications1
- Arbing R1
- Armon C1
- Barohn RJ1
- Barsdorf A1
- Buchsbaum R1
- Chen X1
- Das M1
- Gan B1
- Clinical Coordinating Center1
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation1
- Life Sciences Institute and Department of Molecular1
- School of Medicine1
- The Barer Institute1
- The University of Texas MD Anderson Cancer Center1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials